Wai Yuen Tong Medicine Holdings Limited (00897.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 4Aug 7Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

HKD 343.16M

MomentumView details →

1D Return

−3.17%

YTD Return

−21.79%

RSI (14)

51.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

HKD 343.16M

RSI (14)

51.8

MomentumView details →

1D Return

−3.17%

YTD Return

−21.79%

ProfitabilityView details →

Gross Margin

51.68%

Net Margin

0.78%

EBITDA Margin

5.82%

ROE (TTM)

0.94%

ROA (TTM)

0.68%

Asset Turnover

0.86x

GrowthView details →

Revenue YoY

−30.99%

EPS YoY

+133.79%

FCF YoY

+40.93%

Revenue CAGR 3Y

−19.01%

EPS CAGR 3Y

−42.86%

EBITDA YoY

−75.19%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

1.40x

Quick Ratio

0.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

+248.50%

Financials snapshotView financials →

Revenue (TTM)

1.43B

Net Income (TTM)

11.09M

Op. CF (TTM)

225.60M

Latest newsMore news →

Wai Yuen Tong Medicine Company Limited sold its subsidiary Crown Zun (Shenzhen) Commerce Development Company Limited for 99.8 million yuan (approximately 115 million Hong Kong dollars).50d ago

Hong An Group, through its indirect wholly-owned subsidiary Wai Yuen Tong, agreed to sell a target company holding a property in Shenzhen for approximately HKD 115 million.50d ago

Similar companies

SNDL Inc.SNDL Embecta Corp.EMBC Alpha Teknova, Inc.TKNO Emergent BioSolutions Inc.EBS Canopy Growth CorporationCGC China NT Pharma Group Company Limited01011.HK Find similar companies →

Latest newsMore news →

Wai Yuen Tong Medicine Company Limited sold its subsidiary Crown Zun (Shenzhen) Commerce Development Company Limited for 99.8 million yuan (approximately 115 million Hong Kong dollars).50d ago Hong An Group, through its indirect wholly-owned subsidiary Wai Yuen Tong, agreed to sell a target company holding a property in Shenzhen for approximately HKD 115 million.50d ago